Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US5455265A · kind A · utility
202Cited by
33References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 11, 1993 |
| Grant date | Oct 3, 1995 |
| Priority date | — |
| Expiry date | Feb 11, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Process of treatment of mammals, including humans to treat diseases or conditions of the type which are normally treated with retinoid-like compounds is disclosed, with pharmaceutical compositions containing an active compound which is a selective agonist of the RXR retinoid receptor sites in preference to the RAR retinoid receptor sites. A compound is defined to be a selective agonist of the RXR receptor site if the compound is at least approximately ten times more effective as an agonist in the RXR receptor sites than in the RAR receptor sites.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.